Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol vs Aspirin for Carotid Atherosclerosis in Type 2 Diabetes (FANCY)
NCT03248401Phase 4Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Sep 2016
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol in carotid atheroma (CAS), sponsored by Seoul National University Bundang Hospital. Started Sep 2016; status: completed.
02
Drugs
cilostazol
03
Conditions
carotid atheroma (CAS)
Beyond the preview
Go deeper on NCT03248401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03248401.